Elham Hedayati
Impact in
-
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
Papers in
- Oncology 26
- Cancer Treatment and Pharmacology 8
- Cancer survivorship and care 6
- HER2/EGFR in Cancer Research 5
-
- Chemotherapy-induced cardiotoxicity and mitigation 11
- Heart Failure Treatment and Management 4
- Co-authors
- Maria Albertsson (3 shared papers)Hassan Alinaghizadeh (3 shared papers)Maryam Hazrati (2 shared papers)Håkan Nyman (3 shared papers)Sareh Keshavarzi (1 shared paper)Marzieh Momennasab (1 shared paper)Jonas Bergh (13 shared papers)Kenny A. Rodriguez‐Wallberg (4 shared papers)
In The Last Decade
Elham Hedayati
39 papers receiving 430 citations
Peers
Comparison fields: 5 of 80
- Internal Medicine 26
- Oncology 165
- Health 46
- Reproductive Medicine 42
- Genetics 42
Countries citing papers authored by Elham Hedayati
This map shows the geographic impact of Elham Hedayati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Hedayati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Hedayati more than expected).
Fields of papers citing papers by Elham Hedayati
This network shows the impact of papers produced by Elham Hedayati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Hedayati. The network helps show where Elham Hedayati may publish in the future.
Co-authors
The 25 scholars most cited alongside Elham Hedayati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 56 | |
| 2 | 2011 | 41 | |
| 3 | 2020 | 36 | |
| 4 | 2016 | 35 | |
| 5 | 2019 | 33 | |
| 6 | 2012 | 26 | |
| 7 | 2021 | 20 | |
| 8 | 2011 | 19 | |
| 9 | 2019 | 14 | |
| 10 | 2020 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2022 | 12 | |
| 13 | 2016 | 11 | |
| 14 | 2015 | 11 | |
| 15 | 2016 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2019 | 10 | |
| 18 | 2021 | 9 | |
| 19 | 2022 | 8 | |
| 20 | 2023 | 8 |
About Elham Hedayati
Elham Hedayati is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Public Health, Environmental and Occupational Health, having authored 44 papers that have together received 438 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (11 papers), Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (8 papers), Cancer-related cognitive impairment studies (7 papers), Cancer survivorship and care (6 papers), HER2/EGFR in Cancer Research (5 papers), Heart Failure Treatment and Management (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). The work is most often cited by research in Internal Medicine (26 citations), Oncology (165 citations), Health (46 citations), Reproductive Medicine (42 citations) and Genetics (42 citations). Elham Hedayati has collaborated with scholars based in Sweden, Germany and Austria. Frequent co-authors include Maria Albertsson, Hassan Alinaghizadeh, Maryam Hazrati, Håkan Nyman, Sareh Keshavarzi, Marzieh Momennasab, Jonas Bergh, Kenny A. Rodriguez‐Wallberg, Anna Marklund and Frida E. Lundberg. Their work appears in journals such as Scientific Reports, Cancers, Journal of Clinical Oncology, Cancer and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.